Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2022. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 22.6B USD
- Positions
- 961
- Share of the ten largest
- 11.9%
The ten largest positions Q3 2022
- Biogen 2.0%▲ +268.1%
- T-Mobile US 1.4%▼ −20.0%
- Alibaba Group (ADR) 1.2%▲ +489.7%
- AstraZeneca 1.2%▲ +144.0%
- Meta Platforms 1.2%▲ +89.3%
- Fidelity National Information Services 1.1%▲ +67.8%
- Palo Alto Networks 1.0%▲ +112.1%
- Arista Networks 1.0%▲ +4.6%
- Microsoft 1.0%▲ +148.0%
- Amazon 0.9%▲ +40.0%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q3 2022
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Bunge Limited | 0.2% | 556,300 | 45.9M USD | +563.1% increased | Q2 2014 or earlier 34 quarters |
| Xenon Pharmaceuticals Inc | 0.3% | 1,640,072 | 59.2M USD | +81.9% increased | Q1 2015 31 quarters |
| AMZN Amazon | 0.9% | 1,837,862 | 207.7M USD | +40.0% increased | Q1 2017 23 quarters |
| PANW Palo Alto Networks | 1.0% | 1,413,942 | 231.6M USD | +112.1% increasedafter 3:1 stock split | Q1 2018 19 quarters |
| Sanofi | 0.3% | 1,727,777 | 65.7M USD | +446.8% increased | Q1 2018 19 quarters |
| LVS Las Vegas Sands | 0.4% | 2,199,307 | 82.5M USD | +47.2% increased | Q3 2018 17 quarters |
| American Finl Group Inc Ohio | 0.3% | 633,459 | 77.9M USD | +84.3% increased | Q4 2018 16 quarters |
| FIS Fidelity National Information Services | 1.1% | 3,331,045 | 251.7M USD | +67.8% increased | Q1 2019 15 quarters |
| Select Sector SPDR TR | 0.7% | 2,108,000 | 151.8M USD | +51.7% increased | Q1 2019 15 quarters |
| Childrens Pl Inc New | < 0.1% | 209,323 | 6.5M USD | +363.1% increased | Q1 2019 15 quarters |
| JBL Jabil | 0.5% | 2,063,000 | 119.1M USD | +4.1% increased | Q2 2019 14 quarters |
| Cytokinetics Inc | < 0.1% | 32,000 | 1.6M USD | +63.0% increased | Q2 2019 14 quarters |
| TRGP Targa Resources | 0.1% | 515,900 | 31.1M USD | +79.5% increased | Q3 2019 13 quarters |
| Neoleukin Therapeutics Inc | < 0.1% | 2,064,222 | 1.3M USD | +43.6% increased | Q4 2019 12 quarters |
| AZN AstraZeneca | 1.2% | 4,811,660 | 263.9M USD | +144.0% increased | Q1 2020 11 quarters |
| MSFT Microsoft | 1.0% | 957,370 | 223.0M USD | +148.0% increased | Q1 2020 11 quarters |
| DHR Danaher Corporation | 0.3% | 285,623 | 73.8M USD | +113.1% increased | Q1 2020 11 quarters |
| Exelixis Inc | < 0.1% | 923,700 | 14.5M USD | +80.2% increased | Q1 2020 11 quarters |
| META Meta Platforms | 1.2% | 1,932,078 | 262.1M USD | +89.3% increased | Q2 2020 10 quarters |
| ADI Analog Devices | 0.9% | 1,422,672 | 198.2M USD | +148.9% increased | Q2 2020 10 quarters |
| GM General Motors | 0.6% | 4,130,470 | 132.5M USD | +72.6% increased | Q2 2020 10 quarters |
| Uniqure NV | 0.4% | 4,259,886 | 79.9M USD | +11.5% increased | Q2 2020 10 quarters |
| CB Chubb Limited | 0.3% | 423,191 | 77.0M USD | +99.0% increased | Q2 2020 10 quarters |
| Radnet Inc | 0.2% | 1,811,974 | 36.9M USD | +22.0% increased | Q2 2020 10 quarters |
| Elastic N V | 0.1% | 444,538 | 31.9M USD | +16.4% increased | Q2 2020 10 quarters |
| Allete Inc | < 0.1% | 343,100 | 17.2M USD | +96.2% increased | Q2 2020 10 quarters |
| WRB W. R. Berkley Corporation | < 0.1% | 157,450 | 10.2M USD | +21.6% increased | Q2 2020 10 quarters |
| Melco Resorts And Entmnt Ltd | < 0.1% | 1,530,198 | 10.1M USD | +78.6% increased | Q2 2020 10 quarters |
| Angi Inc | < 0.1% | 1,875,814 | 5.5M USD | +10.3% increased | Q2 2020 10 quarters |
| Ringcentral Inc | < 0.1% | 54,385 | 2.2M USD | +1,130.2% increased | Q2 2020 10 quarters |
| BIIB Biogen | 2.0% | 1,677,982 | 448.0M USD | +268.1% increased | Q3 2020 9 quarters |
| CSX CSX Corporation | 0.6% | 4,808,127 | 128.1M USD | +201.4% increased | Q3 2020 9 quarters |
| Arcutis Biotherapeutics Inc | 0.3% | 3,785,277 | 72.3M USD | +90.5% increased | Q3 2020 9 quarters |
| Antero Resources Corp | 0.3% | 2,323,286 | 70.9M USD | +9.3% increased | Q3 2020 9 quarters |
| Biomarin Pharmaceutical Inc | 0.2% | 595,400 | 50.5M USD | +302.6% increased | Q3 2020 9 quarters |
| CRL Charles River Laboratories | 0.2% | 211,900 | 41.7M USD | +1,360.1% increased | Q3 2020 9 quarters |
| Markel Corp | 0.1% | 24,969 | 27.1M USD | +39.5% increased | Q3 2020 9 quarters |
| Transalta Corp | < 0.1% | 1,810,372 | 16.0M USD | +370.2% increased | Q3 2020 9 quarters |
| Azure Pwr Global Ltd | < 0.1% | 239,253 | 1.3M USD | +48.1% increased | Q3 2020 9 quarters |
| Vnet Group Inc | < 0.1% | 54,900 | 302.0K USD | +6,000.0% increased | Q3 2020 9 quarters |
| Inspire Med Sys Inc | 0.4% | 488,672 | 86.7M USD | +66.3% increased | Q4 2020 8 quarters |
| Chinook Therapeutics Inc | 0.2% | 2,440,754 | 48.0M USD | +0.9% increased | Q4 2020 8 quarters |
| CCEP Coca-Cola Europacific Partners | < 0.1% | 491,103 | 20.9M USD | +191.0% increased | Q4 2020 8 quarters |
| Ultragenyx Pharmaceutical In | < 0.1% | 350,687 | 14.5M USD | +28.2% increased | Q4 2020 8 quarters |
| Pulmonx Corp | < 0.1% | 526,797 | 8.8M USD | +33.8% increased | Q4 2020 8 quarters |
| Alphatec HLDGS Inc | < 0.1% | 915,200 | 8.0M USD | +28.7% increased | Q4 2020 8 quarters |
| ANET Arista Networks | 1.0% | 1,977,909 | 223.3M USD | +4.6% increased | Q1 2021 7 quarters |
| APA APA Corporation | 0.5% | 3,102,505 | 106.1M USD | +139.1% increased | Q1 2021 7 quarters |
| MSI Motorola Solutions | 0.4% | 427,995 | 95.9M USD | +181.9% increased | Q1 2021 7 quarters |
| Sarepta Therapeutics Inc | 0.4% | 851,900 | 94.2M USD | +100.2% increased | Q1 2021 7 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 297 positions.
Plus 367 option positions, value of the underlying shares as reported 2.0B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 328.4M USD
- SPDR S&P 500 ETF TR Call 103.3M USD
- Invesco Db Multi-Sector Comm Call 90.1M USD
- Gsk PLC Call 72.1M USD
- Ishares TR Put 58.3M USD
- Select Sector SPDR TR Call 53.3M USD
- Medical Pptys Trust Inc Put 51.3M USD
- Apple Inc. Put 39.0M USD
- Microsoft Put 32.1M USD
- Sanofi Call 28.5M USD
Plus 44 positions in convertible bonds and bonds worth 400.1M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Novavax Inc principal 38.9M USD 38.2M USD
- Dish Network Corporation principal 37.0M USD 24.3M USD
- Royal Caribbean Group principal 21.4M USD 20.2M USD
- Spotify USA Inc principal 24.5M USD 19.4M USD
- Ford Mtr Co Del principal 20.8M USD 19.1M USD
- Avalara Inc principal 18.5M USD 17.9M USD
- Docusign Inc principal 17.5M USD 16.4M USD
- Ringcentral Inc principal 18.2M USD 15.3M USD
- Wayfair Inc principal 18.1M USD 15.1M USD
- Sarepta Therapeutics Inc principal 9.0M USD 15.0M USD
Breakdown by sector
- Technology 12.2%
- Consumer Discretionary 7.6%
- Health Care 7.5%
- Financials 6.1%
- Industrials 4.0%
- Communication Services 3.8%
- Utilities 3.2%
- Consumer Staples 2.5%
- Energy 2.4%
- Materials 1.8%
- Real Estate 1.2%
- not in our coverage 47.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors